With 1.84 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.26 million shares. The 52-week range on CGNX shows that it touched its highest point at $53.13 and its lowest point at $32.41 during that stretch. It currently has a 1-year price target of $43.09. With its current market cap of 5.67 billion, CGNX has annualized dividend of $0.30 while the current yield stands at 0.91%. Beta for the stock currently stands at 1.40.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CGNX was down-trending over the past week, with a drop of -14.90%, but this was down by -18.58% over a month. Three-month performance dropped to -15.68% while six-month performance fell -15.59%. The stock lost -12.40% in the past year, while it has lost -6.86% so far this year. A look at the trailing 12-month EPS for CGNX yields 0.61 with Next year EPS estimates of 1.15. For the next quarter, that number is 0.13. This implies an EPS growth rate of 39.46% for this year and 33.02% for next year. EPS is expected to grow by 30.25% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -11.96%.
Float and Shares Shorts:
At present, 170.43 million CGNX shares are outstanding with a float of 169.38 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CGNX since 13 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.64671 being high and $0.57384 being low. For CGNX, this leads to a yearly average estimate of $0.61938. Based on analyst estimates, the high estimate for the next quarter is $0.33 and the low estimate is $0.21. The average estimate for the next quarter is thus $0.25.